Lp(a): When to Measure it and What to Do About it

Collaborative CME and Research Network

M. O'Donoghue

Should Colchicine Become Standard Therapy for CAD?

Collaborative CME and Research Network

P. Ridker

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

Recent Cholesterol Guidelines and Integration into Clinical Practice

Vasculearn Network

J. Plutzky, L. Braun, J. Ross

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

Coronary Calcium Testing: Principles and Clinical Application

Right Care Initiative

A. Taylor

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

Scripps Health

N. Lepor

Postural Tachycardia Syndrome: Pathophysiology and Impact of Tragus …

Virtual EP Connect

V. Reddy, F. Marchlinski, T. Glotzer, B. Olshansky, S. Po, S. Stavrakis

CRT 2025 Insights: Artificial Intelligence Based System for Identify…

CRT 2025 Insights

Y. Feld

I Ordered an Lp(a) Level – Now What?

Collaborative CME and Research Network

M. O'Donoghue

Year in Review: 6 Pillars of Health - Practical Guide to Formulating…

Sara Bajuyo

Exercise Guidance for Patients on GLPs

Dr. Carolynn Francavilla

C. Francavilla Brown

The History of Invasive Cardiac Procedures - Updated

Joel Gorfinkel

Big Questions About Lipoprotein “Little” (a)

MUSC Cardiology

A. Arana Waring

Exercise Medicine: 2024 Updates

Baylor College of Medicine

A. Cortez